Postbiotics Market to Reach USD 224.8 Million by 2030, Growing at a CAGR of 8.9%

The global postbiotics market size is estimated to be valued at USD 146.7 million in 2025 and is projected to reach USD 224.8 million by 2030, registering a CAGR of 8.9% during the forecast period (2025–2030), according to a research report published by MarketsandMarkets.

The market is witnessing increasing demand driven by growing consumer awareness of gut health, microbiome balance, and preventive healthcare. Postbiotics, consisting of non-living microbial cells and their metabolites, offer health benefits without requiring live microorganisms. Their superior stability, safety, and ability to withstand challenging processing conditions make them suitable for various applications, including functional foods and beverages, dietary supplements, animal feed, cosmetics and personal care, and pharmaceuticals.

Request Custom Data to Address your Specific Business Needs

Key factors driving the postbiotics market include:

  • Growing consumer interest in gut health, immunity, digestive wellness, and microbiome-friendly products.
  • Increasing preference for stable microbial ingredients that offer health benefits without requiring live microorganisms.
  • Rising demand for functional foods, beverages, and dietary supplements with scientifically supported health benefits.
  • Growing application of postbiotics in skincare and personal care products due to their anti-inflammatory, antioxidant, and skin-barrier-supporting properties.
  • Increasing investments in microbial research, product innovation, and advanced postbiotic manufacturing technologies.

Key Market Segments and Growth Opportunities

  • By Form: The dry form segment is expected to register the fastest growth during the forecast period. Postbiotic powders offer concentrated bioactive compounds, excellent shelf stability, and ease of incorporation into functional foods, beverages, smoothies, cereals, and snack bars. Their heat-stable properties also simplify manufacturing and allow integration into existing production systems. Growing consumer preference for convenient alternatives to conventional pills, including powders, gummies, and bars, is further supporting segment growth.
  • By Application: The cosmetics & personal care segment is expected to account for a significant postbiotics market share during the forecast period. Increasing consumer interest in skinimalism, clean beauty, and microbiome-friendly skincare is driving the incorporation of postbiotics into moisturizing creams, anti-aging serums, and hair care products. Their multifunctional properties, including anti-inflammatory, antioxidant, and skin-barrier-supporting benefits, make them attractive ingredients for products targeting sensitive, acne-prone, and problematic skin.
  • By Region: Europe is expected to hold a significant share of the global postbiotics market. Growing consumer adoption of dietary supplements, increasing awareness of preventive healthcare, and rising demand for scientifically supported gut-health solutions are supporting regional growth. Strategic collaborations and product innovations are also strengthening the market. In November 2023, AB Biotek Human Nutrition & Health, a subsidiary of Associated British Foods plc (UK), partnered with Tetra Pak (Switzerland) to develop innovative postbiotic solutions for food and beverage applications. The collaboration aims to facilitate the incorporation of postbiotics into products such as dairy, plant-based drinks, and snacks.

Key Companies in the Postbiotics Market

The report profiles prominent postbiotics companies operating in the global market, including:

  • Cargill, Incorporated (US)
  • ADM (US)
  • Kerry Group PLC (Ireland)
  • dsm-firmenich (Netherlands)
  • Associated British Foods plc (UK)
  • BASF (Germany)
  • Novozymes A/S, part of Novonesis Group (Denmark)
  • International Flavors & Fragrances Inc. (US)
  • MCLS Europe B.V. (Netherlands)
  • Phileo by Lesaffre (France)
  • Lallemand Inc. (Canada)
  • Sami-Sabinsa Group (India)
  • CJ CheilJedang Corp. (South Korea)
  • Biotenova Sdn. Bhd. (Malaysia)
  • Bioprox Healthcare (France)

These companies are focusing on product innovation, research and development, strategic collaborations, and the expansion of microbial ingredient portfolios to strengthen their competitive positions in the growing postbiotics market.

The global postbiotics market is poised for steady growth as consumer awareness of gut health, immunity, and microbiome wellness continues to increase. The growing use of postbiotics in functional foods, dietary supplements, and cosmetics & personal care products is creating new opportunities for ingredient manufacturers. Furthermore, the advantages of dry formulations, including enhanced stability, convenient processing, and versatility across applications, are expected to support market expansion. Continued innovation and strategic partnerships will further strengthen the role of postbiotics in next-generation health, nutrition, and personal care products.

Share this post:

Related Posts

Comments are closed.